Latest news
H.C. Wainwright Maintains SAB Biotherapeutics(SABS.US) With Buy Rating, Maintains Target Price $10 - MoomooMoomoo · Sat, 08 Aug 2026 10:22:56 GMTSAB Biotherapeutics Inc (SABS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 15:16:38 GMTSAB Biotherapeutics Q2 Earnings Call Highlights - MarketBeatMarketBeat · Fri, 07 Aug 2026 12:04:20 GMTSAB Biotherapeutics Inc (SABS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKeyTradingKey · Fri, 07 Aug 2026 09:28:17 GMTSAB Biotherapeutics (NASDAQ:SABS) Posts Earnings Results, Hits Estimates - MarketBeatMarketBeat · Fri, 07 Aug 2026 00:21:02 GMTSAB Biotherapeutics Inc (SABS) (Q2 2026) Earnings Call Highlights: Advancing SAB142 with Strong ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:14:21 GMTSAB BIO Reports Q2 2026 Results, Expands SAB-142 Type 1 Diabetes Trials and Secures Breakthrough T1D Grant for PRISE-hATG Study - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:44:00 GMTPress Release: SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights - MoomooMoomoo · Thu, 06 Aug 2026 11:30:00 GMT